Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies

Item

http://www.wikidata.org/entity/Q33333473

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies

@ast

Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies

@en

Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies.

@nl

type

Item

label

Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies

@ast

Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies

@en

Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies.

@nl

prefLabel

Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies

@ast

Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies

@en

Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies.

@nl

P1476

Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies

@en

P2093

A K Sood

http://www.w3.org/2001/XMLSchema#string

B Anderson

http://www.w3.org/2001/XMLSchema#string

J I Sorosky

http://www.w3.org/2001/XMLSchema#string

J S Skilling

http://www.w3.org/2001/XMLSchema#string

R C Squatrito

http://www.w3.org/2001/XMLSchema#string

R E Buller

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer.

Phase I trial of carboplatin and infusional cyclosporin in advanced malignancy.

Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study.

Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patients.

Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance.

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.

Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.

Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme.

P-glycoproteins in pathology: the multidrug resistance gene family in humans.

Molecular basis of cisplatin resistance in human carcinomas: model systems and patients.

P304

118-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.NEO.7900019

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1999-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12387720

http://www.w3.org/2001/XMLSchema#string

P698

10933045

http://www.w3.org/2001/XMLSchema#string

P932

1508129

http://www.w3.org/2001/XMLSchema#string